go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Virginia rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $3,548 · 10th–90th $3,388$6,7610%50%10th90th$3,548Professionalmedian $3,548 · 10th–90th $2,570$4,1690%50%10th90th$3,548$1.0$5.0$20.0$100.0$500.0$2.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,388.44
Median
$3,548.13
Typical High
$3,890.45
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,187.76
Median
$3,388.44
Typical High
$3,548.13
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$5,248.07
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$3,388.44
Median
$3,388.44
Typical High
$3,388.44
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,715.35
Median
$6,918.31
Typical High
$8,912.51
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$3,388.44
Median
$4,073.80
Typical High
$5,754.40
Medcost
Setting
Facility
Modifier
Global
Typical Low
$2,344.23
Median
$4,168.69
Typical High
$6,309.57
United
Setting
Facility
Modifier
Global
Typical Low
$4,168.69
Median
$6,760.83
Typical High
$8,912.51
United
Setting
Professional
Modifier
Global
Typical Low
$4,073.80
Median
$4,168.69
Typical High
$4,466.84